187 results on '"Garratt, Chris"'
Search Results
2. ODM-209, a CYP 11A1 inhibitor in patients with mCRPC: Results from the STESIDES phase 1 study.
3. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
4. Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
5. Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
6. MK-5684 (ODM-208), a CYP11A1 inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) with and without AR-LBD mutations: CYPIDES phase 2 results.
7. Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
8. Real-world assessment of AR-LBD mutations in metastatic castration-resistant prostate cancer.
9. Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure
10. A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
11. Impact of activating androgen receptor (AR) mutations on AR sensitivity to alternative ligands and response to ODM-208, a selective, first-in-class CYP11A1 inhibitor, in patients with advanced metastatic castration-resistant prostate cancer (mCRPC).
12. Phase 1 results of the ODM-208 first-in-human phase 1-2 trial in patients with metastatic castration-resistant prostate cancer (CYPIDES).
13. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
14. Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
15. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial
16. Determinants of clinical response to levosimendan in the REFALS phase 3 study in people with ALS (4104)
17. Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
18. Dexmedetomidine vs Midazolam or Propofol for Sedation During Prolonged Mechanical Ventilation: Two Randomized Controlled Trials
19. Abstracts from the 31st International Symposium on ALS/MND.
20. Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study
21. Dose escalation study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours.
22. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
23. Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
24. Some Odd Answers.
25. Res Extensa.
26. A Quiet Life in Holland.
27. The Early Days of Science.
28. PART THREE: THE GENEALOGY OF POSTMODERN HISTORY.
29. PART TWO: THE GENEALOGY OF POSTMODERN THEORY.
30. PART ONE: THE GENEALOGY Of POSTMODERN ART.
31. Introducing Ethics.
32. ETHICS AND EUTHANASIA.
33. ETHICS AND ANIMALS.
34. A Brief History of Ethics.
35. Setting the Stage.
36. Influence of antipsychotic profile on cost of treatment of schizophrenia: A decision analysis approach
37. The Postmodern Mind.
38. Lessons at 5 A.M.
39. Can Computers Understand?
40. Trialism Explains Sensations.
41. Mind-Body Interaction.
42. Observations on leading 'techies'.
43. The Postmodern Condition.
44. Descartes' Legacy.
45. Descartes and Ethics.
46. Retirement.
47. Humans and Computers.
48. Functionalism.
49. Problems.
50. Aspects of Consciousness.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.